PT-2026-34067 · Oracle · Oracle Life Sciences Empirica Signal+1

Published 2026-04-21 · Updated 2026-05-01 · CVE-2026-21997

Positive Technologies (AI Summary)

CVSS v3.1

8.5

High

Base vector

AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N

Name of the Vulnerable Software and Affected Versions Oracle Life Sciences Empirica Signal versions 9.2.1 through 9.2.3

Description An issue in the Common Core component allows a low privileged attacker with network access via HTTP to compromise the system. Successful exploitation can lead to unauthorized read access to a subset of data, as well as unauthorized creation, deletion, or modification of critical data or all accessible data within the product. This may also significantly impact additional products due to a scope change.

Recommendations At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Improper Access Control

Weakness Enumeration

CWE-284

Related Identifiers

CVE-2026-21997

Affected Products

Oracle Life Sciences Empirica Signal

Life Sciences Empirica Signal

References · 4

• https://nvd.nist.gov/vuln/detail/CVE-2026-21997 · Security Note
• https://oracle.com/security-alerts/cpuapr2026.html · Vendor Advisory
• https://twitter.com/CVEnew/status/2048910144160125281 · Twitter Post
• https://t.me/cveNotify/161722 · Telegram Post